Adia Nutrition, Inc. revenue by segment ADIA

Adia Nutrition, Inc. splits its revenue into 4 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Medical Procedures at $329,820, 68% of the total.

USD in millions. The percent under a figure is the change from the same quarter a year earlier.

Line
TTM
Jun 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Revenue
—
0
0
Medical Procedures
—
0
share 68.0%
0
share 59.5%
Sales Of Biologics
—
0
share 31.3%
0
share 39.6%
Sales Of Prducts And Services
—
—
0
share 39.6%
Shipping And Delivery
—
0
share 0.8%
0
share 0.9%
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as
ADIA (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Winter Park, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1160420
Former names
Adia Nutrition, Inc. (until Aug 24, 2026); PivX Solutions, Inc. (until Jul 17, 2013); DRILLING INC (until Apr 21, 2004)

Other Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.